BioSpace News Archive

Weight loss

Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar

Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.

March 6, 2026
·
3 min read
·
Tristan Manalac
Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

Servier will pick up Ojemda, which received FDA approval in 2024 to treat pediatric glioma. The drug clocked sales of $155 million for Day One Biopharmaceuticals in 2025.

March 6, 2026
·
1 min read
·
Annalee Armstrong
Press Releases

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

March 6, 2026
·
5 min read
FDA

FDA’s Prasad To Depart FDA Following Tumultuous Term as CBER Chief

Center for Biologics Evaluation and Research Director Vinay Prasad will exit the FDA for the second time after a controversial run that saw the oncologist butt heads with colleagues and ruffle feathers in biopharma after presiding over the rejection of several rare disease therapies.

March 6, 2026
·
3 min read
·
Heather McKenzie